“Descriptive Analysis of Reported Adverse Events Associated With Amoxicillin Clavulanate Potassium”. Asian Journal of Pharmaceutics (AJP), vol. 16, no. 3, Sept. 2022, https://doi.org/10.22377/ajp.v16i3.4493.